4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-23-046109
Pres&Chief Investment Officer acquired 27,790 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Sukhatme Mayukh · Pres&Chief Investment Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-09-27 | Exercise or conversion : show line 1 in the form | +27,790 | 3,217,750 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-27 | Exercise or conversion : show line 2 in the form Capped Value Appreciation Rights | −53,033 | $6.40 | $339,411 | 2,015,263 | D |
| 2023-09-27 | Exercise or conversion : show line 3 in the form Capped Value Appreciation Rights | −28,411 | $11.50 | $326,727 | 1,335,300 | D |
Loading xslF345X05/form4.xml…